naproxen has been researched along with Innate Inflammatory Response in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (13.83) | 18.7374 |
1990's | 14 (14.89) | 18.2507 |
2000's | 19 (20.21) | 29.6817 |
2010's | 39 (41.49) | 24.3611 |
2020's | 9 (9.57) | 2.80 |
Authors | Studies |
---|---|
Kreft, AF; Musser, JH | 1 |
Ackerman, N; Ballaron, SA; Galeazzi, E; Greenhouse, R; Guzmán, A; Muchowski, JM; Peréz, V; Rovito, JR; Tomolonis, AJ; Young, JM | 1 |
Ackrell, J; Cooper, GF; Halpern, O; Kluge, AF; Koehler, R; Muchowski, JM; Simon, RL; Unger, SH; Van Horn, AR; Wren, DL | 1 |
Doulgkeris, CM; Eleftheriou, PT; Galanakis, D; Gavalas, AM; Kourounakis, AP; Kourounakis, PN; Rekka, EA; Tsiakitzis, KC; Victoratos, P | 1 |
Bakthavatchalam, R; Blum, CA; Boyce, S; Brielmann, H; Burnaby-Davies, N; Caldwell, T; Capitosti, S; Chenard, BL; Conley, R; Cortright, D; Crandall, M; De Lombaert, S; Hodgetts, KJ; Jones, AB; Kershaw, MT; Krause, JE; Martin, WJ; Mason, G; Matson, D; Murphy, BA; Perrett, H; Rycroft, W; Zheng, X | 1 |
Afzal, O; Bawa, S; Chawla, G; Deora, GS; Kalle, AM; Kumar, S; Mulakayala, N; Rajaram, A; Rathore, V; Tonk, RK | 1 |
Abbadie, C; Bugianesi, RM; Chakravarty, PK; Dai, G; Duffy, JL; Garcia, ML; Green, M; Haedo, RJ; Herrington, JB; Jochnowitz, N; Kaczorowski, GJ; Li, X; Lyons, KA; McGowan, E; McManus, OB; Mistry, S; Shao, PP; Smith, MM; Sun, SY; Swensen, AM; Varughese, DJ; Warren, VA; Ye, F | 1 |
Arhancet, GB; Baratta, MT; Carter, JS; Fobian, YM; Hayes, MJ; Heasley, SE; Jerome, GM; Jones, DE; Masferrer, JL; Metz, S; Moore, WM; Shaffer, AF; Springer, JR; Vazquez, ML; Walker, DP; Zweifel, B | 1 |
Guo, L; He, G; He, J; Ouyang, L; Pan, J; Shi, J; Wei, J; Zhang, J; Zhou, R | 1 |
Ertan, M; Kazkayasi, I; Okay, G; Ozadali-Sari, K; Sarigol, D; Somuncuoglu, EI; Tel, BC; Tozkoparan, B; Unsal-Tan, O; Uzgoren-Baran, A | 1 |
Anastácio Furtado Pacheco, P; Arruda, JC; Bello, ML; Castro, HC; da Silva, FC; Dantas, LP; de Freitas, HR; de Melo Reis, RA; Faria, RX; Ferreira, LBG; Ferreira, VF; Gonzaga, DTG; Moreira Maramaldo Costa, TE; Penido, C; Rodrigues, CR; Sposito Simões, AP; von Ranke, NL | 1 |
Gou, S; Liu, Z; Wang, C; Zhou, W | 1 |
Abdel-Daim, MM; Akhtar, MF; Alsharif, KF; Saleem, A; Zubair, S | 1 |
Flint, JD; Gilroy, DW; Glanville, JRW; Hosin, AA; Jalali, P; Maini, AA; Patel, AA; Wallace, JL | 1 |
Aguilar, MR; Al-Khoury, H; Espinosa-Cano, E; Groth, T; Román, JS; Schmidt, G; Syrowatka, F | 1 |
Alnouti, Y; Desouza, CV; Heineman, R; Saraswathi, V; Shivaswamy, V | 1 |
Bolognesi, MP; Hsueh, MF; Kraus, VB; Wellman, SS | 1 |
Almáši, M; Bednarčík, J; Hudák, A; Šuleková, M; Szücsová, J; Váhovská, L; Zeleňák, V; Zeleňáková, A; Žid, L | 1 |
Eleftheriou, P; Gavalas, A; Geronikaki, A; Haroun, M; Kamoutsis, C; Kochkar, H; Nair, AB; Paparisva, A; Petrou, A; Tratrat, C; Venugopala, KN | 1 |
Dang, F; Hao, R; Lan, B; Mu, Y; Wang, R; Wu, Y | 1 |
Chang, C; Chen, Y; Han, J; Hua, X; Li, D; Li, L; Li, Z; Liu, Z; Wang, Q; Wang, Z | 1 |
Jarosz, M; Librowski, T; Marona, H; Młyniec, K; Nowak, G; Szkaradek, N | 1 |
Baek, JS; Lee, YH; Loo, SCJ; Tan, NS; Yeo, EW | 1 |
Radhakrishnan, J; Radhakrishnan, R; Yellepeddi, VK | 1 |
Chen, Z; Cheng, L; Feng, G | 1 |
Almutairi, A; Hamelmann, N; Lee, S; Stubelius, A; Tran, V | 1 |
Afraei, S; Hosseini, M; Jamshidi, AR; Khadem Azarian, S; Mahmoudi, M; Mirshafiey, A; Mostafaei, S; Nazeri, S; Vojdanian, M | 1 |
Bolboacă, SD; Bulboacă, AC; Bulboacă, AE; Dogaru, G; Porfire, AS; Stănescu, IC; Suciu, ȘM; Tefas, LR | 1 |
Christoph, T; Leipelt, A; Pasqualon, T; Read, SJ; Robens, A; Rutten, K; Schiene, K | 1 |
Bahde, R; Gupta, S; Kapoor, S | 1 |
Das, MR; Dastidar, P; Deb, J; Jana, SS; Majumder, J | 1 |
Eissa, SI; Farrag, AM; Galeel, AA | 1 |
Nalamachu, S; Wortmann, R | 1 |
Gouveia, FS; Lopes, LG; Lucetti, LT; Medeiros, JV; Ribeiro, RA; Santana, AP; Soares, PM; Sousa, EH; Souza, MH; Tavares, BM | 1 |
Gemici, B; Wallace, JL | 1 |
Bercik, P; Blackler, RW; Buret, AG; Da Silva, GJ; De Palma, G; Flannigan, KL; Manko, A; Surette, MG; Wallace, JL | 1 |
Dixit, D; Ilango, K; Kathiravan, MK; Kumar, G; Nilewar, S; Valentina, P | 1 |
Bentley, JP; Brewer, CB; Day, LB; Waddell, DE | 1 |
Dendrinou-Samara, C; Georgiadou, V; Makris, G; Papagiannopoulou, D; Vourlias, G | 1 |
Olender, D; Pawełczyk, A; Sowa-Kasprzak, K; Zaprutko, L | 1 |
El Azhary, NM; Mostafa, DK; Nasra, RA | 1 |
Brozoski, DT; Calvo, AM; Dionísio, TJ; Faria, FA; Lauris, JR; Santos, CF; Simoneti, LF; Torres, EA; Weckwerth, GM; Zupelari-Gonçalves, P | 1 |
González-Gay, MA; González-Juanatey, C | 1 |
Dial, EJ; Lichtenberger, LM; Moore, JE; Romero, JJ | 1 |
Danhof, M; Della Pasqua, OE; Huntjens, DR; Spalding, DJ | 1 |
Han, CD; Kim, YH; Lee, JW; Paik, S; Yoo, JH; Yoon, DS | 1 |
Haberer, LJ; Lener, SE; McDonald, SA; Taylor, DR; Walls, CM | 1 |
Aguilar-Robles, P; Castañeda-Hernández, G; González-García, MP; Ortiz, MI; Ponce-Monter, HA | 1 |
Ghosal, K; Pimplikar, SW; Stathopoulos, A | 1 |
Bani, D; Bolla, M; Masini, E; Pini, A; Viappiani, S | 1 |
Armagan, G; Kanit, L; Yalcin, A | 1 |
Barbosa, AL; Bezerra, TS; Carvalho, NS; Chaves, LS; Damasceno, SR; Freitas, AL; Medeiros, JV; Oliveira, CB; Santana, AP; Silva, RO; Soares, PM; Souza, MH | 1 |
Backhouse, N; Delporte, C; Feliciano, SA; López-Pérez, JL; Negrete, R | 1 |
Evans, R | 1 |
Bobbaers, HJ; Knockaert, DC; Peetermans, WE; Vanderschueren, S | 1 |
Roach, JT; Sufka, KJ | 1 |
Lovell, DJ; Sullivan, K; Zaoutis, TE | 1 |
Branch, CD; Gopalan, B; Ito, I; Ramesh, R; Roth, JA; Stephens, C | 1 |
Jain, NK; Kulkarni, SK; Sharma, S | 1 |
Augustyniak, ME; Cochran, ED; Earl, RA; Ellis, JL; Garvey, DS; Gordon, LJ; Janero, DR; Khanapure, SP; Letts, LG; Melim, TL; Murty, MG; Schwalb, DJ; Selig, WM; Shumway, MJ; Trocha, AM; Young, DV; Zemtseva, IS | 1 |
Cirino, G; Distrutti, E; Wallace, JL | 1 |
Hilário, MO; Len, CA; Terreri, MT | 1 |
Atmaca, Y; Erol, C; Gulec, S; Ozdol, C; Rahimov, U; Turhan, S | 1 |
Barrett, TD; Hong, TT; Huang, J; Lucchesi, BR | 1 |
Ballaron, SJ; De Young, LM; Puhvel, SM; Spires, DA; Young, JM | 1 |
Colombo, G; Glässer, A; Luzzani, F; Schiatti, P; Selva, D | 1 |
Ballaron, SJ; Bedord, CJ; De Young, LM; Spires, DA; Wagner, B; Young, JM | 1 |
Snow, D | 1 |
Ferrari Parabita, G; Rossi, D; Scalvini, F; Scaricabarozzi, I; Zanetti, U | 1 |
Bechi, P; Nava, ML; Panconesi, R; Scaricabarozzi, I; Zuckermann, M | 1 |
Casini-Raggi, V; Cominelli, F; Laine, L; Marin-Sorensen, M; Sloane, R; Weinstein, WM | 1 |
Breton, J; Griswold, DE; Marshall, PJ; Torphy, TJ; Webb, EF; White, JR | 1 |
Clarke, GD; MacPherson, IS; Petrone, G; Spangler, RS | 1 |
Castañeda-Hernández, G; Favari, L; Hoyo-Vadillo, C | 1 |
Griswold, DE; Tzimas, MN | 1 |
Medvedeff, ED; Nickerson-Nutter, CL | 1 |
Aabakken, L; Meling, TR; Osnes, M; Røseth, A | 1 |
Akatsu, T; Consolaro, A; Guimarães, SA; Tago, EM | 1 |
Asselin, I; Célestin, F; Entman, M; Goulet, M; Guérette, B; Huard, C; Roy, B; Roy, R; Skuk, D; Tardif, F; Tremblay, JP | 1 |
Cullen , DJ; Doherty, M; Garner, S; Garrud, P; Hawkey, CJ; Holmes, S; Logan, RF; Maynard, A; Seager, JM; Wilson, JV | 1 |
Asfaha, S; McKnight, W; Muscará, MN; Wallace, JL | 1 |
Bucci, M; Calignano, A; Cicala, C; Cirino, G; Fiorucci, S; Gerli, R; Ianaro, A; Santucci, L; Wallace, JL | 1 |
Asanuma, M; Kohno, M; Miyazaki, I; Nishibayashi-Asanuma, S; Ogawa, N | 1 |
Fyllingen, G; Haugstvedt, JR; Husby, T; Skoglund, LA | 1 |
Ito, M; Suzuki, Y; Yamagami, I | 1 |
Anttila, M; Dean, PB; Doherty, NS | 1 |
Adamska-Dyniewska, H; Dziekański, S; Goch, JH; Kowalczyk, L; Rec, A; Szeszko, A; Tkaczewski, W | 1 |
Calhoun, W; Carlson, RP; Copenhaver, TW; Datko, LJ; Gilman, SC | 1 |
Castellanos, R; Feria Velasco, A; López-Fiesco, A; Mejia, S; Zamora Lopez, G | 1 |
Griswold, DE; Hanna, N; Schwartz, L; Webb, E | 1 |
Gustafson, GT; Lerner, UH | 1 |
Ferrari Parabita, S; Maffi, F; Moniaci, D; Pellati, D; Rivetti, M | 1 |
Baracos, VE; Gale, R; Whitmore, WT | 1 |
4 review(s) available for naproxen and Innate Inflammatory Response
Article | Year |
---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
Role of indomethacin in acute pain and inflammation management: a review of the literature.
Topics: Acute Pain; Anti-Inflammatory Agents, Non-Steroidal; Humans; Indomethacin; Inflammation; Ketorolac; Naproxen; Oxycodone; Piroxicam; Tramadol; Treatment Outcome | 2014 |
Nitric oxide and inflammation.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Aspirin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Inflammation; Naproxen; Nitrates; Nitric Oxide | 2006 |
Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors.
Topics: Adolescent; Aspirin; Celecoxib; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etoricoxib; Fever; Humans; Hypersensitivity, Immediate; Inflammation; Leukotrienes; Meloxicam; Naproxen; Pain; Prostaglandins; Pyrazoles; Pyridines; Sulfonamides; Sulfones; Thiazines; Thiazoles; Treatment Outcome | 2006 |
12 trial(s) available for naproxen and Innate Inflammatory Response
Article | Year |
---|---|
Potent anti-inflammatory effects of an H
Topics: Adolescent; Adult; Dinoprostone; Escherichia coli; Humans; Hydrogen Sulfide; Inflammation; Male; Middle Aged; Monocytes; Naproxen; Neutrophils; Pain; Phenotype; Solubility; Ultraviolet Rays; Vasoconstriction; Young Adult | 2021 |
A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation.
Topics: Adipose Tissue; Adult; Biopsy; Cyclooxygenase Inhibitors; Dyslipidemias; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Inflammation; Male; Middle Aged; Naproxen; Obesity; Overweight; Pilot Projects; Prospective Studies; Triglycerides | 2020 |
The safety and efficacy of Guluronic acid (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Hexuronic Acids; Humans; Inflammation; Male; Naproxen; Spondylitis, Ankylosing; Treatment Outcome | 2019 |
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Celecoxib; Cognition Disorders; Double-Blind Method; Female; Humans; Inflammation; Longitudinal Studies; Male; Naproxen; Physical Examination; Pyrazoles; Sulfonamides; Treatment Outcome | 2013 |
Efficacy of naproxen with or without esomeprazole for pain and inflammation in patients after bilateral third molar extractions: A double blinded crossover study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Humans; Inflammation; Male; Molar, Third; Naproxen; Pain Management; Pain, Postoperative; Proton Pump Inhibitors; Tooth Extraction; Treatment Outcome; Young Adult | 2017 |
Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Compounding; Drug Synergism; Female; Humans; Inflammation; Male; Middle Aged; Migraine Disorders; Naproxen; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome | 2010 |
Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Clopidogrel; Creatine Kinase, MB Form; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammation; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Naproxen; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome; Troponin I | 2007 |
A controlled clinical study of the efficacy and tolerability of nimesulide vs naproxen in maxillo-facial surgery.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Face; Female; Humans; Inflammation; Male; Maxilla; Middle Aged; Naproxen; Postoperative Complications; Sulfonamides; Surgery, Oral | 1993 |
Clinical efficacy and tolerability of nimesulide compared with naproxen in the treatment of posthaemorrhoidectomy pain and inflammation.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Hemorrhoids; Humans; Inflammation; Male; Middle Aged; Naproxen; Pain, Postoperative; Postoperative Complications; Sulfonamides | 1993 |
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Etodolac; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Middle Aged; Naproxen; Prostaglandins; Stomach Ulcer | 1995 |
Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Feces; Gastric Mucosa; Humans; Indomethacin; Inflammation; Intestinal Mucosa; Leukocyte L1 Antigen Complex; Male; Naproxen; Neural Cell Adhesion Molecules; Piroxicam; Reproducibility of Results | 1996 |
Acute postoperative swelling after hand surgery: an exploratory, double-blind, randomised study with paracetamol, naproxen, and placebo.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carpal Tunnel Syndrome; Double-Blind Method; Dupuytren Contracture; Edema; Female; Hand; Humans; Inflammation; Male; Middle Aged; Naproxen | 2001 |
78 other study(ies) available for naproxen and Innate Inflammatory Response
Article | Year |
---|---|
Synthesis and antiinflammatory and analgesic activity of 5-aroyl-6-(methylthio)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-ca rboxyl ic acids and 1-methyl-4-(methylthio)-5-aroylpyrrole-2-acetic acids.
Topics: Acetates; Analgesia; Animals; Aspirin; Benzoquinones; Carboxylic Acids; Carrageenan; Chemical Phenomena; Chemistry; Edema; Inflammation; Mice; Molecular Structure; Pain Measurement; Phenylbutazone; Pyrroles; Quinones; Rats | 1989 |
Synthesis and antiinflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids. The 6-substituted compounds.
Topics: Analgesia; Animals; Carboxylic Acids; Chemical Phenomena; Chemistry; Inflammation; Magnetic Resonance Spectroscopy; Mice; Pyrroles; Rats; Structure-Activity Relationship | 1987 |
Synthesis and pharmacochemical study of novel polyfunctional molecules combining anti-inflammatory, antioxidant, and hypocholesterolemic properties.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antioxidants; Arthritis; Cholesterol; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Female; Inflammation; Pipecolic Acids; Proline; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triglycerides | 2006 |
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
Topics: Analgesics; Animals; Biological Availability; Capsaicin; Chlorocebus aethiops; COS Cells; Hot Temperature; Humans; Hyperalgesia; In Vitro Techniques; Inflammation; Microsomes, Liver; Naphthyridines; Pain; Pyrazines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Rats; Structure-Activity Relationship; TRPV Cation Channels | 2010 |
Synthesis and pharmacological evaluation of pyrazolo[4,3-c]cinnoline derivatives as potential anti-inflammatory and antibacterial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Edema; Escherichia coli; Heterocyclic Compounds, 2-Ring; Inflammation; Lipid Peroxidation; Microbial Sensitivity Tests; Molecular Docking Simulation; Naproxen; Pseudomonas aeruginosa; Pyrazoles; Rats; Rats, Wistar; Staphylococcus aureus; Structure-Activity Relationship; Ulcer | 2012 |
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cells, Cultured; Chronic Pain; Dogs; Humans; Hyperalgesia; Inflammation; Mice; Mice, Knockout; Microsomes, Liver; Neuralgia; Patch-Clamp Techniques; Piperidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tissue Distribution | 2012 |
Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.
Topics: Anti-Inflammatory Agents; Drug Discovery; Enzyme Inhibitors; Humans; Inflammation; Intramolecular Oxidoreductases; Prostaglandin-E Synthases; Structure-Activity Relationship | 2013 |
Design, synthesis and biological evaluation of enzymatically cleavable NSAIDs prodrugs derived from self-immolative dendritic scaffolds for the treatment of inflammatory diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dendrimers; Drug Delivery Systems; Drug Design; Humans; Inflammation; Magnetic Resonance Spectroscopy; Mice; Naproxen; Prodrugs; Stomach Ulcer | 2013 |
Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Drug Design; Edema; Humans; Inflammation; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Naproxen; Nociception; Pain; Pain Measurement; Structure-Activity Relationship; Thiazoles; Thiones; Triazoles | 2015 |
1-Aryl-1H- and 2-aryl-2H-1,2,3-triazole derivatives blockade P2X7 receptor in vitro and inflammatory response in vivo.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Inflammation; Lipopolysaccharides; Mice; Molecular Structure; Pleurisy; Receptors, Purinergic P2X7; Structure-Activity Relationship; Triazoles | 2017 |
Hypoxia-Activated Prodrugs with Dual COX-2/CA Inhibitory Effects on Attenuating Cardiac Inflammation under Hypoxia.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Hypoxia; Inflammation; Nitroreductases; Prodrugs | 2022 |
Comparison of individual and combination treatments with naproxen, prednisolone and hydroxychloroquine to treat Complete Freund's Adjuvant induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Experimental; Erythrocytes; Female; Freund's Adjuvant; Humans; Hydroxychloroquine; Inflammation; Male; Naproxen; Oxidative Stress; Prednisolone; Rats; Rats, Wistar | 2021 |
Anti-inflammatory Surface Coatings Based on Polyelectrolyte Multilayers of Heparin and Polycationic Nanoparticles of Naproxen-Bearing Polymeric Drugs.
Topics: Anti-Inflammatory Agents; Cell Adhesion; Cell Line; Chitosan; Coated Materials, Biocompatible; Heparin; Humans; Inflammation; Interleukin-1beta; Macrophages; Nanoparticles; Naproxen; Polyelectrolytes; Polymers; Polystyrenes; Surface Properties | 2019 |
Anti-inflammatory effects of naproxen sodium on human osteoarthritis synovial fluid immune cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dinoprostone; Flow Cytometry; Humans; Hyaluronic Acid; Inflammation; Interleukin-1beta; Interleukin-6; Interleukin-8; Lipopolysaccharides; Macrophages; Monocytes; Naproxen; Neutrophils; NF-kappa B; Osteoarthritis, Knee; Synovial Fluid; T-Lymphocytes; THP-1 Cells; Tumor Necrosis Factor-alpha | 2020 |
Mesoporous Silica as a Drug Delivery System for Naproxen: Influence of Surface Functionalization.
Topics: Adsorption; Anti-Inflammatory Agents, Non-Steroidal; Drug Delivery Systems; Humans; Inflammation; Naproxen; Porosity; Silicon Dioxide; Solvents; Surface Properties | 2020 |
New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Female; Humans; Inflammation; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Molecular Docking Simulation; Naproxen; Structure-Activity Relationship; Triazoles | 2021 |
The protective effects of naproxen against interleukin-1β (IL-1β)- induced damage in human umbilical vein endothelial cells (HUVECs).
Topics: Cell Adhesion; Cytokines; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-1beta; Naproxen; Protective Agents; Signal Transduction; THP-1 Cells | 2021 |
Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Inflammation; Mice; Nanoparticles; Naproxen; Platinum; Serum Albumin, Bovine | 2021 |
Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Carrageenan; Edema; Gastric Mucosa; Ibuprofen; Inflammation; Male; Naproxen; Organometallic Compounds; Rats; Rats, Wistar; Zinc; Zinc Compounds | 2017 |
Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Capsules; Celecoxib; Cimetidine; Delayed-Action Preparations; Diffusion; Drug Combinations; Drug Compounding; Drug Liberation; Drug Stability; Gastric Juice; Histamine H2 Antagonists; Ibuprofen; Inflammation; Kinetics; Models, Chemical; Nanocapsules; Nanotechnology; Naproxen; Polymers; Solubility; Technology, Pharmaceutical | 2017 |
Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Celecoxib; Chromatography, Liquid; Comparative Effectiveness Research; Diclofenac; Disease Models, Animal; Ibuprofen; Inflammation; Male; Naproxen; Pelvic Pain; Prostate; Prostatitis; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2018 |
Bone inflammation and chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; C-Reactive Protein; Child; Child, Preschool; Diagnosis, Differential; Diphosphonates; Female; Humans; Inflammation; Magnetic Resonance Imaging; Male; Naproxen; Osteomyelitis; Tumor Necrosis Factor-alpha | 2018 |
Inflammation-Responsive Drug-Conjugated Dextran Nanoparticles Enhance Anti-Inflammatory Drug Efficacy.
Topics: Animals; Anti-Inflammatory Agents; Dextrans; Drug Liberation; Dynamic Light Scattering; Hydrogen Peroxide; Hydrogen-Ion Concentration; Inflammation; Macrophages; Mice; Nanoparticles; Naproxen; Particle Size; RAW 264.7 Cells; Time Factors | 2018 |
Liposomal Curcumin Enhances the Effect of Naproxen in a Rat Model of Migraine.
Topics: Animals; Antioxidants; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Inflammation; Male; Migraine Disorders; Naproxen; Oxidative Stress; Pain; Pain Measurement; Rats; Rats, Wistar | 2019 |
Burrowing as a non-reflex behavioural readout for analgesic action in a rat model of sub-chronic knee joint inflammation.
Topics: Analgesia; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Chronic Disease; Disease Models, Animal; Ibuprofen; Inflammation; Knee Joint; Male; Naproxen; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Reflex | 2014 |
Nonselective inhibition of prostaglandin-endoperoxide synthases by naproxen ameliorates acute or chronic liver injury in animals.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclooxygenase 1; Cyclooxygenase 2; End Stage Liver Disease; Hepatocytes; Inflammation; Male; Membrane Proteins; Naproxen; Necrosis; Rats; Rats, Inbred F344 | 2014 |
Designing a simple organic salt-based supramolecular topical gel capable of displaying in vivo self-delivery application.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Drug Design; Gels; Imiquimod; Inflammation; Male; Mice; Naproxen; Peptides; Salts | 2014 |
Non-carboxylic analogues of aryl propionic acid: synthesis, anti-inflammatory, analgesic, antipyretic and ulcerogenic potential.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antipyretics; Carrageenan; Disease Models, Animal; Edema; Fever; Inflammation; Male; Mice; Naphthalenes; Naproxen; Pain; Propionates; Rats; Rats, Wistar; Ulcer | 2014 |
The nitric oxide donor cis-[Ru(bpy)2(SO3)NO](PF6) increases gastric mucosa protection in mice--involvement of the soluble guanylate cyclase/K(ATP) pathway.
Topics: 2,2'-Dipyridyl; Animals; Cytokines; Ethanol; Gastric Mucosa; Guanylate Cyclase; Inflammation; KATP Channels; Mice; Naproxen; Nitrates; Nitric Oxide Donors; Nitrites; Organometallic Compounds; Peroxidase; Protective Agents; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2015 |
Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Gastrointestinal Tract; Gene Expression Regulation; Humans; Hydrogen Sulfide; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Naproxen; Neurodegenerative Diseases; Pain; Protective Agents; Signal Transduction; Spinal Cord Injuries | 2015 |
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Hepatobiliary Elimination; Hydrogen Sulfide; Inflammation; Intestinal Diseases; Male; Naproxen; Proton Pump Inhibitors; Rats, Wistar; RNA, Ribosomal, 16S | 2015 |
Design, synthesis and QSAR studies on a series of 2, 5-disubstituted- 1,3,4-oxadiazole derivatives of diclofenac and naproxen for analgesic and anti-inflammatory activity.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Design; Female; Inflammation; Male; Mice; Molecular Structure; Naproxen; Oxadiazoles; Pain; Pain Measurement; Quantitative Structure-Activity Relationship; Rats | 2015 |
Resistance exercise and naproxen sodium: effects on a stable PGF2α metabolite and morphological adaptations of the upper body appendicular skeleton.
Topics: Adaptation, Physiological; Adult; Bones of Upper Extremity; Cyclooxygenase Inhibitors; Dinoprost; Double-Blind Method; Exercise; Humans; Inflammation; Male; Naproxen; Prostaglandin-Endoperoxide Synthases; Resistance Training; Young Adult | 2015 |
Octadecylamine-Mediated Versatile Coating of CoFe2O4 NPs for the Sustained Release of Anti-Inflammatory Drug Naproxen and in Vivo Target Selectivity.
Topics: Amines; Animals; Anti-Inflammatory Agents; Cobalt; Drug Delivery Systems; Ferric Compounds; Humans; Inflammation; Magnetite Nanoparticles; Mice; Naproxen; Particle Size; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2016 |
Hybrid Compounds Strategy in the Synthesis of Oleanolic Acid Skeleton-NSAID Derivatives.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Ibuprofen; Inflammation; Ketoprofen; Molecular Structure; Naproxen; Oleanolic Acid | 2016 |
The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine.
Topics: Allyl Compounds; Animals; Arginine; Cognitive Dysfunction; Hydrogen Sulfide; Inflammation; Inflammation Mediators; Male; Maze Learning; Naproxen; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Sulfides | 2016 |
Inflammation: NSAIDs and cardiovascular risk in arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Humans; Ibuprofen; Inflammation; Naproxen; Risk Factors | 2017 |
Naproxen-PC: a GI safe and highly effective anti-inflammatory.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Gastrointestinal Hemorrhage; Glycine max; Inflammation; Lecithins; Naproxen; Rats; Synovial Fluid | 2009 |
Impact of chronic inflammation on the pharmacokinetic-pharmacodynamic relationship of naproxen.
Topics: Animals; Dinoprostone; Dose-Response Relationship, Drug; Freund's Adjuvant; Inflammation; Naproxen; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 2010 |
The effects of COX-2 inhibitor during osteogenic differentiation of bone marrow-derived human mesenchymal stem cells.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Bone Marrow Cells; Celecoxib; Cell Differentiation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Male; Mesenchymal Stem Cells; Middle Aged; Naproxen; Osteogenesis; Pyrazoles; RNA, Messenger; Sulfonamides; Young Adult | 2010 |
Synergistic effect of the interaction between naproxen and citral on inflammation in rats.
Topics: Acyclic Monoterpenes; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Drug Synergism; Edema; Herb-Drug Interactions; Inflammation; Male; Monoterpenes; Naproxen; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Stomach Diseases | 2010 |
APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation.
Topics: Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ibuprofen; Immunohistochemistry; In Vitro Techniques; Inflammation; Male; Mice; Mice, Transgenic; Naproxen; Nerve Tissue Proteins; Neurogenesis; Nuclear Proteins | 2010 |
Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Bleomycin; Collagen; Cyclooxygenase Inhibitors; Deoxyguanosine; Dinoprostone; Inflammation; Lung; Male; Mice; Mice, Inbred C57BL; Naproxen; Nitrates; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Peroxidase; Propionates; Prostaglandin-Endoperoxide Synthases; Pulmonary Fibrosis; Thiobarbiturates; Transforming Growth Factor beta | 2012 |
Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Inflammation; Lipid Peroxidation; Malondialdehyde; Mefenamic Acid; Naproxen; Neuroprotective Agents; Oxidative Stress; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Serine | 2012 |
A sulfated-polysaccharide fraction from seaweed Gracilaria birdiae prevents naproxen-induced gastrointestinal damage in rats.
Topics: Animals; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Glutathione; Gracilaria; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Naproxen; Peroxidase; Polysaccharides; Rats; Rats, Wistar | 2012 |
Bioactive phenolic derivatives from Acaena splendens methanol extract.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Carrageenan; Catechin; Chromones; Edema; Female; Fever; Flavonoids; Glucosides; Guinea Pigs; Hindlimb; Inflammation; Kaempferols; Magnetic Resonance Spectroscopy; Male; Medicine, Traditional; Molecular Structure; Naproxen; Phenols; Phytotherapy; Plant Extracts; Rabbits; Rosaceae | 2002 |
Inflammation 2003-Sixth World Congress. Nitric oxide and IBD. 2-6 August 2003, Vancouver, Canada.
Topics: Animals; British Columbia; Cyclooxygenase Inhibitors; Drugs, Investigational; Humans; Inflammation; Internationality; Irritable Bowel Syndrome; Naproxen; Nitric Oxide | 2003 |
Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Fever of Unknown Origin; Humans; Inflammation; Naproxen; Neoplasms | 2003 |
Characterization of the chick carrageenan response.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Chickens; Cyclooxygenase Inhibitors; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edema; Hyperalgesia; Inflammation; Morphine; Naproxen; Pain Measurement; Reaction Time; Time Factors | 2003 |
Immunosuppressants, infection, and inflammation.
Topics: Arthralgia; Arthritis, Juvenile; Child, Preschool; Fever; Humans; Immunosuppressive Agents; Infections; Inflammation; Male; Methotrexate; Naproxen | 2004 |
Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Dinoprostone; Female; Gene Expression; Genetic Therapy; Humans; Inflammation; Lung Neoplasms; Mice; Nanostructures; Naproxen; RNA-Binding Protein FUS; Signal Transduction; Transcription Factor AP-1; Transgenes | 2004 |
Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspartame; Carrageenan; Drug Interactions; Edema; Inflammation; Mice; Morphine; Naproxen; Narcotics; Pain; Pain Measurement; Pentazocine; Rats; Rats, Wistar; Sulfonamides; Sweetening Agents; Time Factors | 2005 |
NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Edema; Gastric Mucosa; Humans; In Vitro Techniques; Inflammation; Male; Molecular Structure; Naphthalenes; Naproxen; Neutrophil Infiltration; Nitric Oxide Donors; Protective Agents; Rats; Rats, Sprague-Dawley; Vasodilation | 2005 |
Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
Topics: Acetylcholine; Animals; Arachidonic Acid; Benzofurans; Carotid Arteries; Coronary Circulation; Coronary Vessels; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Epoprostenol; Inflammation; Ligation; Lipopolysaccharides; Naproxen; Platelet Aggregation; Propionates; Pyrazoles; Receptors, Epoprostenol; Sulfonamides; Thrombosis; Time Factors; Vasodilation; Vasodilator Agents | 2008 |
Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne.
Topics: Acne Vulgaris; Animals; Benzoyl Peroxide; Disease Models, Animal; Erythromycin; Female; Fluocinolone Acetonide; Inflammation; Injections, Intradermal; Naproxen; Propionibacterium acnes; Pyrazoles; Rats; Rats, Inbred Strains; Tetracycline; Tretinoin | 1984 |
Inhibition of PG production by MDL 035, a new non-steroidal non-acidic anti-inflammatory compound, in rat gastric mucosa and inflammatory exudate.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dinoprostone; Dose-Response Relationship, Drug; Exudates and Transudates; Gastric Mucosa; Imidazoles; In Vitro Techniques; Indomethacin; Inflammation; Male; Naproxen; Prostaglandins; Prostaglandins E; Rats; Stomach Ulcer | 1984 |
The mouse ear inflammatory response to topical arachidonic acid.
Topics: Administration, Topical; Animals; Arachidonic Acid; Arachidonic Acids; Cell Division; DNA; Dose-Response Relationship, Drug; Ear, External; Edema; Erythema; Female; Inflammation; Mice; Naproxen; Prostaglandin-Endoperoxide Synthases; Skin; Vasodilation | 1984 |
Non-steroidal anti-inflammatory agents in the horse.
Topics: Animals; Anti-Inflammatory Agents; Clonixin; Horse Diseases; Horses; Inflammation; Meclofenamic Acid; Naproxen; Phenylbutazone | 1981 |
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Calcimycin; Cells, Cultured; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 4; Ear, External; Eicosanoids; Histamine Release; Humans; Imidazoles; Inflammation; Leukotriene B4; Male; Mast Cells; Mice; Mice, Inbred BALB C; Monocytes; Nadolol; Naproxen; Neutrophils; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrazoles; Pyrrolidinones; Receptors, Adrenergic, beta; Rolipram; SRS-A; Thiazoles | 1993 |
Antinociceptive effects of non-steroidal anti-inflammatory drugs in a rat model of unilateral hindpaw inflammation.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-Response Relationship, Drug; Inflammation; Injections, Intramuscular; Male; Naphthaleneacetic Acids; Naproxen; Pain; Rats; Rats, Wistar | 1994 |
Pharmacokinetics and pharmacodynamics of naproxen in acute experimental hepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Carrageenan; Chemical and Drug Induced Liver Injury; Galactosamine; Inflammation; Injections, Intravenous; Liver Function Tests; Liver Regeneration; Male; Naproxen; Protein Binding; Rats; Rats, Wistar | 1993 |
Ultraviolet B-induced inflammatory cytokine production, in vivo: initial pharmacological characterization.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dose-Response Relationship, Radiation; Inflammation; Mice; Mice, Inbred BALB C; Naproxen; Peroxidase; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 1995 |
The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chronic Disease; Disease Models, Animal; Drug Combinations; Exudates and Transudates; Female; Hydroxyurea; Inflammation; Leukotriene B4; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Naproxen; Prostaglandin-Endoperoxide Synthases; Quinolines; Time Factors; Zymosan | 1996 |
Assessment of the antiexudative and antiproliferative activities of non-steroidal anti-inflammatory drugs in inflammatory models developed in rats by subcutaneous implantation of bacterial cell walls from the dental plaque.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Cell Division; Cell Wall; Child; Dental Plaque; DNA Replication; Duodenum; Edema; Exudates and Transudates; Granuloma; Growth Inhibitors; Humans; Ibuprofen; Indomethacin; Inflammation; Intestinal Mucosa; Naproxen; Rats; Sulindac | 1996 |
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; beta-Galactosidase; Biomarkers; Cell Adhesion; Cell Death; Cell Line, Transformed; Fluoresceins; Genes, Reporter; Graft Rejection; Immunosuppressive Agents; Inflammation; Interleukin-1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Naproxen; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; Piroxicam; Radiation Chimera; Stem Cell Transplantation; Tacrolimus; Whole-Body Irradiation; Zymosan | 1997 |
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Prescriptions; Family Practice; Humans; Ibuprofen; Inflammation; Medical Records Systems, Computerized; Middle Aged; Naproxen; Patient Compliance; Pharmacoepidemiology; United Kingdom | 2000 |
Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Collagen; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Exudates and Transudates; Gastric Mucosa; Inflammation; Isoenzymes; Male; Membrane Proteins; Naproxen; Nitrates; Nitric Oxide Donors; Nitrites; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Thromboxanes; Wound Healing | 2000 |
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Dose-Response Relationship, Drug; Edema; Flow Cytometry; Hindlimb; Inflammation; Interleukin-1; Male; Naproxen; Nitric Oxide; Nociceptors; Pain; Pain Measurement; Rats; Rats, Inbred Lew; Receptors, Interleukin-2; T-Lymphocytes; Thymidine; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzoates; Cell Death; Cell Line; Cell Nucleus; Cell Survival; Dexamethasone; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Humans; Hydrocortisone; Imidazoles; Indomethacin; Inflammation; Mefenamic Acid; Naproxen; Neuroblastoma; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Rats; Tumor Cells, Cultured | 2001 |
Mechanism of action of a new anti-inflammatory agent, naproxen (II). Effects of naproxen on activities of mucopolysaccharase, acid protease and collagenolytic enzymes in inflamed tissues.
Topics: Adenosine Triphosphatases; Animals; Anti-Inflammatory Agents; Exudates and Transudates; Female; Glucuronidase; Glycosaminoglycans; Granuloma; Inflammation; Lyases; Microbial Collagenase; Muramidase; Naphthaleneacetic Acids; Naproxen; Protease Inhibitors; Rats; Time Factors | 1976 |
Penetration of naproxen and salicylate into inflammatory exudates in the rat.
Topics: Animals; Exudates and Transudates; Inflammation; Naphthaleneacetic Acids; Naproxen; Protein Binding; Rats; Serum Albumin, Radio-Iodinated; Sodium; Sodium Salicylate | 1977 |
[Methoxypropriocin in the treatment of inflammatory and degenerative diseases of the locomotor system].
Topics: Adolescent; Adult; Aged; Humans; Inflammation; Middle Aged; Naphthaleneacetic Acids; Naproxen; Rheumatic Diseases | 1976 |
Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Benzimidazoles; Bone and Bones; Carrageenan; Connective Tissue; Drug Interactions; Edema; Gastrointestinal Diseases; Inflammation; Male; Naproxen; Rats; Rats, Sprague-Dawley | 1992 |
Naproxen effects during acute inflammation produced by Staphylococcus aureus and by thinner structural study.
Topics: Animals; Inflammation; Male; Naproxen; Rats; Rats, Inbred Strains; Skin; Solvents; Staphylococcus aureus | 1992 |
Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Ibuprofen; Imidazoles; Inflammation; Male; Masoprocol; Mice; Mice, Inbred BALB C; Naproxen; Peritonitis; Piroxicam; Pyrazoles; Thiazoles | 1987 |
Blood coagulation and bone metabolism: some characteristics of the bone resorptive effect of thrombin in mouse calvarial bones in vitro.
Topics: Adrenal Cortex Hormones; Animals; Arachidonic Acid; Arachidonic Acids; Bone and Bones; Bone Matrix; Bone Resorption; Calcitonin; Calcium; In Vitro Techniques; Indomethacin; Inflammation; Lactates; Lysosomes; Meclofenamic Acid; Mice; Naproxen; Phosphates; Rats; Thrombin | 1988 |
[Analgesic and anti-inflammatory treatment with sodium naproxen in odontostomatology].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Inflammation; Male; Middle Aged; Naproxen; Pain, Postoperative; Surgery, Oral | 1988 |
The metabolic cost of fever.
Topics: Animals; Body Temperature Regulation; Endotoxins; Energy Metabolism; Fever; Humans; Inflammation; Naproxen; Sheep | 1987 |